HealthEquity (NASDAQ:HQY) Shares Down 6.5% – What’s Next?

HealthEquity, Inc. (NASDAQ:HQY)’s stock price fell 6.5% during trading on Monday . The stock traded as low as $88.01 and last traded at $88.0690. 135,262 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 834,084 shares. The stock had previously closed at $94.15.

Analyst Ratings Changes

Several brokerages have recently commented on HQY. Citigroup restated an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. JPMorgan Chase & Co. upped their price target on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. Finally, BTIG Research reiterated a “buy” rating and issued a $130.00 price target on shares of HealthEquity in a report on Thursday, December 4th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $119.60.

HealthEquity Price Performance

The firm has a market cap of $7.22 billion, a P/E ratio of 38.79, a PEG ratio of 1.36 and a beta of 0.20. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The stock’s 50-day simple moving average is $97.04 and its two-hundred day simple moving average is $95.14.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same quarter in the previous year, the business earned $0.78 earnings per share. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,459 shares of company stock valued at $1,483,062 in the last quarter. 1.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC boosted its position in HealthEquity by 232.4% during the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares in the last quarter. True Wealth Design LLC grew its position in shares of HealthEquity by 3,522.2% in the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after buying an additional 317 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in shares of HealthEquity in the 2nd quarter worth approximately $33,000. Cullen Frost Bankers Inc. raised its stake in shares of HealthEquity by 172.3% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after acquiring an additional 224 shares in the last quarter. Finally, Sellwood Investment Partners LLC purchased a new stake in HealthEquity during the second quarter valued at approximately $58,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.